- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05243615
Internet-delivered Cognitive Behavioural Therapy for Persons With Stroke
March 15, 2023 updated by: Swati Mehta, Lawson Health Research Institute
Internet-delivered Cognitive Behavioural Therapy for Persons With Stroke: Randomized Controlled Trial
Approximately 30% of people with stroke experience symptoms of depression.
Many may benefit from access to mental health services that target unhelpful thoughts, such as cognitive behaviour therapy (CBT), but go untreated due to lack of access to specialized care, costs, remote location, or stigma related to seeking care.
Internet Cognitive Behavioural Therapy (ICBT) may overcome these barriers.
The stroke ICBT program teaches skills such as challenging unhelpful thoughts, memory and attention, managing related physical symptoms, and pacing through a mix of online learning and weekly contact with a trained Guide.
While the program's content was found to be acceptable among individuals after stroke, the program's effectiveness still needs to be evaluated.
Thus, the primary purpose of this study is to evaluate if the stroke ICBT program will improve symptoms of depression compared to an attention control group.
Individuals in both groups will answer questions about themselves and their injury and describe symptoms of depression, quality of life, and health service use to evaluate its impact on people's wellbeing.
The study results will be useful in determining if the ICBT program is effective and whether it should be part of routine clinical practice.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Swati Mehta, PhD
- Phone Number: 42359 519-661-2111
- Email: swati.mehta@sjhc.london.on.ca
Study Contact Backup
- Name: Shannon Janzen
- Phone Number: 41295 519-661-2111
- Email: shannon.janzen@sjhc.london.on.ca
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older;
- Canadian residents;
- diagnosed with a stroke at least 6 months ago;
- endorsing symptoms of depression (PHQ-9≥5); 5) suicide risk score <8 (Suicide Behaviours Questionnaire);
- speak and read English;
- able to access and be comfortable using computers and the internet;
- willing to provide a physician as an emergency contact.
Exclusion Criteria:
- significant cognitive impairment, a score of <21 on the Telephone Interview for Cognitive Status;
- aphasia, with significant language impairment;
- currently involved in another psychotherapeutic intervention;
- present with a severe mental health disorder requiring in-person therapy (e.g., severe suicidal ideation, severe substance abuse, a recent history of psychosis or mania).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stroke internet delivered cognitive behavioural therapy
A 10-week internet-delivered cognitive behavioural therapy (ICBT) will be delivered to participants who have sustained a stroke.
In addition to the online program, a Guide with experience delivering ICBT will provide support by email or phone call once a week.
The Guide will spend approximately 15 minutes per week/per client.
|
A 10-week internet-delivered cognitive behavioural therapy (ICBT) will be delivered to participants who have sustained a stroke.
In addition to the online program, a Guide with experience delivering ICBT will provide support by email or phone call once a week.
The Guide will spend approximately 15 minutes per week/per client.
|
|
Active Comparator: Stroke Rehabilitation Education
A 10-week stroke-specific rehabilitation education program for stroke patients in usual care at specialized stroke rehabilitation units.
The lessons will include information on spinal cord injury rehabilitation: 1)stroke basics, 2)mental health after stroke, 3)pain after stroke, 4)understanding rehabilitation 5)summary of lessons through an online platform.
A Guide will check in with participants once a week to answer any content-related questions.
The Guide will spend approximately 15 minutes per week/per client.
|
A 10-week stroke-specific rehabilitation education program for stroke patients in usual care at specialized stroke rehabilitation units.
The lessons will include information on spinal cord injury rehabilitation: 1)stroke basics, 2)mental health after stroke, 3)pain after stroke, 4)understanding rehabilitation 5)summary of lessons through an online platform.
A Guide will check in with participants once a week to answer any content-related questions.
The Guide will spend approximately 15 minutes per week/per client.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in depression
Time Frame: baseline, 10 weeks, 3 months
|
Measured by Patient Health Questionnaire - 9 Item (PHQ-9), higher scores indicate worse outcomes
|
baseline, 10 weeks, 3 months
|
|
Change in anxiety
Time Frame: baseline, 10 weeks, 3 months
|
Measured by Generalize Anxiety Disorder - 7 Item (GAD7)higher scores indicate worse outcomes
|
baseline, 10 weeks, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in quality of life symptoms
Time Frame: baseline, 10 weeks, 3 months
|
Measured by VAS on the EuroQol-5D (EQ5D), higher scores indicate better outcomes
|
baseline, 10 weeks, 3 months
|
|
Self-efficacy
Time Frame: baseline, 10 weeks, 3 months
|
Measured by Self-Efficacy for managing Chronic Disease-6 (SEMCD), higher scores indicate better outcomes
|
baseline, 10 weeks, 3 months
|
|
Change in perceived disability
Time Frame: baseline, 10 weeks, 3 months
|
Measured by The World Health Organization Disability Assessment Schedule ,(WHODAS), higher scores indicate worse outcomes
|
baseline, 10 weeks, 3 months
|
|
Treatment credibility
Time Frame: baseline, 10 weeks
|
Measured by Treatment Credibility Questionnaire (TCQ) which contains 4 items.
The first three items range from 0-9 with higher scores indicating better outcome, and the fourth item ranges from 0-100%, with higher scores indicating greater improvement in functioning.
|
baseline, 10 weeks
|
|
Treatment satisfaction
Time Frame: baseline, 10 weeks
|
Measured by Internet-CBT Treatment Satisfaction Measure, higher scores indicate greater satisfaction
|
baseline, 10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert Teasell, MD, Western University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2023
Primary Completion (Anticipated)
September 1, 2023
Study Completion (Anticipated)
September 1, 2023
Study Registration Dates
First Submitted
February 7, 2022
First Submitted That Met QC Criteria
February 7, 2022
First Posted (Actual)
February 17, 2022
Study Record Updates
Last Update Posted (Actual)
March 16, 2023
Last Update Submitted That Met QC Criteria
March 15, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Guided internet delivered cognitive behavioural therapy
-
Uppsala UniversityLinkoeping University; Utah State University; Friedrich-Alexander-Universität...RecruitingPremenstrual Dysphoric DisorderSweden
-
National University of SingaporeAgency for Integrated Care, Singapore; MOH Office for Healthcare Transformation...Not yet recruitingCognitive Behavioral Therapy | Depression and/or Anxiety in the Mild-to-moderate RangeSingapore
-
Linkoeping UniversityOstergotland County Council, Sweden; Medical Research Council of Southeast...Completed
-
University of ReginaMacquarie University, Australia; Government of Saskatchewan, Ministry of HealthRecruitingDepression | AnxietyCanada
-
Lawson Health Research InstituteNot yet recruitingDepression | Stroke | Anxiety | Internet-Delivered Cognitive Behavioural Therapy
-
University of ReginaSaskatchewan Health Research FoundationCompleted
-
Institute of Mental Health, SingaporeCompleted
-
Lawson Health Research InstituteNot yet recruitingDepression | Anxiety | Spinal Cord Injuries | Caregiver Burnout | Internet-Delivered Cognitive Behavioural Therapy
-
Lawson Health Research InstituteRecruitingDepression | Anxiety | Mild Traumatic Brain Injury | Internet-Delivered Cognitive Behavioural TherapyCanada
-
Institute of Mental Health, SingaporeRecruitingDepression | Anxiety DisordersSingapore